Work

Influence of taranabant, a cannabinoid-1 receptor inverse agonist, on pharmacokinetics and pharmacodynamics of warfarin

Year: 2008

Type: article

Source: Advances in Therapy

DOI: 10.1007/s12325-008-0116-9

Authors: Jules I. Schwartz, Stephanie Dunbar, Jinyu Yuan, Susie Li, Adrianna Gipson, Kim Rosko, Amy O. Johnson-Levonas, Kenneth C. Lasseter, Carol Addy, Aubrey S. Stoch, John A. Wagner

Institutions: Merck & Co., Inc., Rahway, NJ, USA (United States), Clinical Pharmacology of Miami

Language: English

Topic: Pharmacogenetics and Drug Metabolism

Subfield: Pharmacology

Field: Pharmacology, Toxicology and Pharmaceutics

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: Bristol-Myers Squibb, Merck

OpenAlex ID: W1978297207

FWCI: 0.302

Cites: 25

Cited by: 3

Related to: 10